Testing a tiny tablet of obefazimod in healthy adults
This study tests how a new form of the medicine obefazimod (a tiny tablet) is absorbed by the body, and whether people find it easy to take. It is for healthy adults ages 18–55 who are not taking other medications and are generally well.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 18 to 55 years old
- Generally healthy (no serious health conditions or chronic infections)
- Not pregnant or breastfeeding, and willing to use birth control if needed
- Have a BMI between 18 and 32, and weigh at least 110 pounds (50 kg)
- No history of gallstones or gallbladder removal
- No smoking or nicotine use in the past 12 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.
This trial tests an experimental oral medication called obefazimod for people with moderate to severe Crohn's disease. It aims to see if the drug can reduce inflammation and improve symptoms when other treatments have not worked well.
This study tests a new medication called HL40626S to see if it is safe in healthy adults. You would take the tablet and have regular checkups to monitor how your body responds.
This study tests a single dose of a new tablet medication (called TRTL-729) in healthy adults. It helps researchers learn how the drug is absorbed and tolerated, which is a first step in developing a treatment.
This study tests a new investigational tablet in healthy adults to see how the body handles it and if it's safe. The results will help guide future research.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
Hear when a new Healthy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.